| Baseline (n = 17) | 6 months (n = 14) | |
| Appearance of the MRI fibroid enhancement | ||
| Homogeneous | 15 (88.24%) | 10 (71.43%) |
| Heterogeneous | 2 (11.77%) | 4 (28.57%) |
| Fibroid necrosis (MRI) | ||
| <50% | - | 1 (7.14%) |
| 50% - 75% | - | 3 (21.43%) |
| >75% | - | 10 (71.43%) |
| MRI T2-weighted signal | ||
| Hypointense and homogeneous | 4 (23.53%) | 0 (0.00%) |
| Hypointense and heterogeneous | 9 (52.94%) | 4 (28.57%) |
| Hyperintense and homogeneous | 1 (5.88%) | 1 (7.14%) |
| Hyperintense and heterogeneous | 3 (17.65%) | 9 (64.29%) |
| Baseline (n = 17) | 6 months (n = 15) | |
| CEUS appearance | ||
| Hypervascular | 17 (100.00%) | 0 (0.00%) |
| Hypovascular | 0 (0.00%) | 1 (7.00%) |
| Avascular | 0 (0.00%) | 14 (93.00%) |